News

Tramway Venture Partners

Tramway Ventures lands state boost for new $40M fund

By Jacob Maranda – New Mexico Inno Reporter September 19, 2023, 05:12pm MDT   There could soon be a lot more venture capital flowing into New Mexico companies thanks to…

Read More...

Tramway Ventures Welcomes Chris Japp as Managing Partner

[Albuquerque, August 21, 2023] – Tramway Ventures, New Mexico’s leading life sciences and healthcare venture capital firm, proudly announces the appointment of Chris Japp as Managing Partner to the firm….

Read More...

Albuquerque’s Tramway Venture Partners raising investment fund for tech companies

By – Collin Krabble, Technology reporter, Albuquerque Business First Nov 9, 2020, 4:25pm EST Albuquerque venture capital firm Tramway Venture Partners is raising a multimillion fund to invest in tech…

Read More...

Armonica Technologies

UNM Technology Accelerates Genomic Sequencing

Today, DNA sequencing is a tortuous process that often takes days and sometimes weeks to read a full human genome, but University of New Mexico researchers may have found a…

Read More...

Pushing the Boundaries of DNA Sequencing

A young company developing technology created at the University of New Mexico (UNM) is on a mission to disrupt the landscape of DNA sequencing. Armonica Technologies, LLC, is developing a…

Read More...

BennuBio

BennuBio Receives SLAS 2022 Ignite Award

February 27, 2022 BennuBio announced it received the Society for Laboratory Automation and Screening (SLAS) prestigious Ignite award at SLAS’s annual International Conference and Exhibition in Boston, MA on February…

Read More...

BennuBio Hires Matthew Hess as COO

BennuBio has hired Matthew Hess as Chief Operations Officer. He has over 20 years experience helping start-up companies bring technology to market. With a background in software engineering and experience…

Read More...

BennuBio moves into larger facility

In response to continuing success of their novel large particle flow cytometer, BennuBio has moved to a larger facility to consolidate engineering, administrative and laboratory in one building. Formerly located…

Read More...

Circular Genomics

Circular Genomics Raises $8.3 Million for Debut of Circular RNA Assay in Precision Psychiatry

ALBUQUERQUE, N.M., Jan. 24, 2024 /PRNewswire/ — Circular Genomics, the global leader in advancing circular RNA biomarkers for precision psychiatry and neurology, today announced the closing of an $8.3 Million Series…

Read More...

Circular Genomics Announces Two Significant Steps Forward in Linking CircRNA to the Detection, Therapy Selection and Monitoring of Depressive Conditions

Albuquerque, NM, July 11, 2023 (GLOBE NEWSWIRE) — Circular Genomics, the global leader in the use of circular RNA (circRNA) biomarkers for precision psychiatry, today announced the results of a…

Read More...

Precision Medicine in Mental Health Company, Circular Genomics, Appoints, Dr. Paul Sargeant as Chief Executive Officer

ALBUQUERQUE, N.M., April 27, 2023 /PRNewswire/ — Circular Genomics, the leading company in developing circular RNA-based precision medicine tools, data and diagnostics for neurology and psychiatry, has appointed Paul Sargeant,…

Read More...

WaveDyn Vision

WaveFront Dynamics Inc. Launches WaveDȳn® Vision Analyzer

ALBUQUERQUE, N.M.–(BUSINESS WIRE)–WaveFront Dynamics Inc., an ophthalmic medical device company, announced today the commercial launch of its dynamic aberrometry measurement system, the WaveDyn Vision Analyzer. The WaveDyn Vision Analyzer (pronounced…

Read More...

WaveFront Dynamics Inc. Initiates $3mm Series A Round to Fund Continued Development of Dynamic Wavefront Measurement System for Vision Correction

ALBUQUERQUE, N.M.–(BUSINESS WIRE)–WaveFront Dynamics Inc. (WaveDyn™), an early stage ophthalmic medical device company, today announced the first close of a $3 million Series A financing round. The round was led by…

Read More...

WaveFront Dynamics Names Jeff Kolberg as New Chief Commercial Officer

ALBUQUERQUE, N.M.–(BUSINESS WIRE)–WaveFront Dynamics Inc. (WaveDyn™), an early stage ophthalmic medical device company, today announced that Jeff Kolberg has been appointed as the company’s Chief Commercial Officer (CCO). Mr. Kolberg…

Read More...

Vitazi.ai

Vitazi.ai Creates a Platform to Deliver Artificial Intelligence to Improve Physician Efficiency and Diagnostics Accuracy

    Vitazi.ai is reimagining image-based diagnostics so providers can gain higher quality, real time & trustable health insights.  October 8, 2021  Albuquerque, New Mexico — Today Tramway Venture Partners…

Read More...